#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type V Immune-mediated myositis Idiopathic pulmonary fibrosis Autoimmune myositis Waldenstrom's macroglobulinaemia recurrent Osteochondrodysplasia Transitional cell cancer of the renal pelvis and ureter Leiomyosarcoma recurrent Tuberous sclerosis complex Mucous membrane pemphigoid Thromboangiitis obliterans Rhabdoid tumour Krabbe's disease Hormone-dependent prostate cancer Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Diagnostics Cystic fibrosis – Diagnostics Netherton’s syndrome – Trials in Disease Anaplastic thyroid cancer Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Breast angiosarcoma – Trials in Disease Alternating hemiplegia of childhood Metachromatic leukodystrophy – Diagnostics Idiopathic inflammatory myopathy – Life with Disease Mantle cell lymphoma stage III – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Exenatide GSKVX000000070965 Plasma L-SERINE Vibostolimab ZALFERMIN Ferric Carboxymaltose Selpercatinib Paracetamol Ph. Eur. Rifamycin Sodium ACT-1004-1239 Lithium Carbonate Specific Nucleic Acid Sna-Xfsa IADADEMSTAT Bms-986442 Baricitinib Briquilimab Dexpanthenol Acetylcysteine VIPOGLANSTAT More therapies…

    Learn about Your Condition

    Skin neoplasm excision Craniotomy Anal cancer stage III Cystic fibrosis Pancreatic fistula Implantation complication Endocrine ophthalmopathy Intervertebral disc protrusion Affective disorder Seasonal allergy Hypoaesthesia Overweight Bartonellosis Synovial sarcoma Autoimmune uveitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of SAT-3247 Compared to Placebo for Patients with Duchenne Muscular Dystrophy Who Can Walk

    Recruiting

    2 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • SAT-3247 OXALATE
    Belgium Poland Spain

  • Long-term safety and effectiveness study of leniolisib for patients with primary immunodeficiency and immune system problems

    Recruiting

    2 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Leniolisib Phosphate
    Spain

  • Study of nivolumab and ipilimumab immunotherapy for organ preservation in patients with advanced head and neck squamous cell carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • A Study of Pacritinib for Reducing Bone Marrow Scarring in Patients with Myelofibrosis Who Have Low Platelet Counts

    Recruiting

    2 1 1
    Investigated Drugs:
    • Pacritinib
    Spain

  • Study of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma metastatic
    Investigated Drugs:
    • Gemcitabine
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Ireland +5

  • A Study of Intravenous Ferric Carboxymaltose on Quality of Life in Older Adults with Acute Coronary Syndrome and Iron Deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Ferric Carboxymaltose
    Spain
Previous Page
1 … 83 84 85 86 87 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!